Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors
Sm. Ametamey et al., Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors, BIOORG MED, 10(1), 2000, pp. 75-78
(D)-7-Iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione (I-PAMQX
), is a potent, in vivo active antagonist acting at the glycine binding sit
e of the NMDA receptor complex. Radioiodinated [I-131]I-PAMQX was prepared
with good yields and high specific activity from its 7-bromo analogue. Biod
istribution studies of [I-131]I-PAMQX in mice showed a relatively slow clea
rance from the blood. The uptake of radioactivity was highest in the kidney
s, moderate in the heart, lung, liver and bones, and low in the brain. (C)
1999 Elsevier Science Ltd. All rights reserved.